{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:18:32Z","timestamp":1788034712126,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tipsro.2026.100428","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:12:16Z","timestamp":1786979536000},"page":"100428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dosimetric impact of daily skin surface variations in kidney stereotactic ablative proton therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Yohan A.","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G.","family":"Moncrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiachien J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Speir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Speir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsi","family":"Hoffnung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Broekhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip F.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylee","family":"Kallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsinshun T.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tipsro.2026.100428_bb0005","doi-asserted-by":"crossref","DOI":"10.1200\/OP.21.00419","article-title":"Clinical review on the management of metastatic renal cell carcinoma","volume":"18","author":"Tran","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.tipsro.2026.100428_bb0010","doi-asserted-by":"crossref","DOI":"10.22465\/juo.234600560028","article-title":"Role of radiotherapy in metastatic renal cell carcinomas: an evolutionary journey in a misunderstood histological type","volume":"21","author":"Wee","year":"2023","journal-title":"J Urol Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2017.01.032","article-title":"Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases","volume":"98","author":"Wang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2026.100428_bb0020","article-title":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies","volume":"2","author":"Zaorsky","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.01.8747","article-title":"Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an eastern cooperative oncology group study (E 6397)","volume":"23","author":"Manon","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2023.02.016","article-title":"Phase 2 trial of stereotactic ablative radiotherapy for patients with primary renal cancer","volume":"84","author":"Hannan","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0035","article-title":"The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis","volume":"5","author":"Correa","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.tipsro.2026.100428_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(24)00731-9","article-title":"Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis","author":"Huang","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(26)00170-1","article-title":"Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials","author":"Siva","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(26)00091-4","article-title":"Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study","author":"Siva","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0060","doi-asserted-by":"crossref","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal Cell Carcinoma","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.tipsro.2026.100428_bb0070","doi-asserted-by":"crossref","DOI":"10.21873\/invivo.12116","article-title":"Proton therapy for primary renal cell carcinoma: the first nationwide retrospective study in Japan","volume":"34","author":"Fukumitsu","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.tipsro.2026.100428_bb0075","doi-asserted-by":"crossref","unstructured":"Frick MA, Chhabra AM, Lin L, Simone, II CB. First ever use of proton stereotactic body radiation therapy delivered with curative intent to bilateral synchronous primary renal cell carcinomas. Cureus 2017. doi:https:\/\/doi.org\/10.7759\/cureus.1799.","DOI":"10.7759\/cureus.1799"},{"key":"10.1016\/j.tipsro.2026.100428_bb0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1186\/s12885-025-14486-1","article-title":"Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): clinical trial protocol","volume":"25","author":"Shaaban","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tipsro.2026.100428_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.03.016","article-title":"A 10-year patterns of use analysis for the world\u2019s first commercial compact pencil beam scanning proton therapy system","author":"Walter","year":"2026","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.tipsro.2026.100428_bb0090","article-title":"In silico comparison of photon versus proton based stereotactic body radiotherapy with increasing maximum peak dose for treatment of primary renal cell carcinoma","volume":"18","author":"Shaaban","year":"2025","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.tipsro.2026.100428_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.semradonc.2023.06.006","article-title":"Advances and challenges in conducting clinical trials with proton beam therapy","volume":"33","author":"Choi","year":"2023","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-248","article-title":"An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy","volume":"8","author":"Siva","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0105","doi-asserted-by":"crossref","DOI":"10.7785\/tcrt.2012.500376","article-title":"Immobilization considerations for proton radiation therapy","volume":"13","author":"Wroe","year":"2014","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.tipsro.2026.100428_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13810","article-title":"Results from the AAPM task group 324 respiratory motion management in radiation oncology survey","volume":"23","author":"Ball","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.tipsro.2026.100428_bb0115","doi-asserted-by":"crossref","DOI":"10.1118\/1.2349696","article-title":"The management of respiratory motion in radiation oncology report of AAPM task group 76","volume":"33","author":"Keall","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.tipsro.2026.100428_bb0120","article-title":"Optimizing QACT frequency in proton therapy: analysis of standard guidelines across treatment sites","volume":"18","author":"Ger","year":"2025","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.tipsro.2026.100428_bb0125","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/accdb2","article-title":"Online adaptive planning methods for intensity-modulated radiotherapy","volume":"68","author":"Qiu","year":"2023","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0130","doi-asserted-by":"crossref","DOI":"10.1088\/0031-9155\/42\/1\/008","article-title":"Adaptive radiation therapy","volume":"42","author":"Yan","year":"1997","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.tipsro.2026.100428_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13961","article-title":"A roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences","volume":"24","author":"Stanley","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.tipsro.2026.100428_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/mp.16941","article-title":"Generation and evaluation of anatomy-preserving virtual CT for online adaptive proton therapy","volume":"51","author":"Kaushik","year":"2024","journal-title":"Med Phys"},{"key":"10.1016\/j.tipsro.2026.100428_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/mp.16625","article-title":"An optimized framework for cone-beam computed tomography-based online evaluation for proton therapy","volume":"50","author":"Chang","year":"2023","journal-title":"Med Phys"}],"container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632426000557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632426000557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:59:57Z","timestamp":1788033597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632426000557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S2405632426000557"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2026.100428","relation":{},"ISSN":["2405-6324"],"issn-type":[{"value":"2405-6324","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric impact of daily skin surface variations in kidney stereotactic ablative proton therapy","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2026.100428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100428"}}